Companies: 10,795·Total market cap: $144.5T
PLx Pharma Inc.

PLx Pharma Inc.

PLXPNASDAQHealthcare
$0.09
+$0.00(+0.00%)
Market Cap$2534980
P/E Ratio
52W High$3.41
52W Low$0.009
Overview

PLx Pharma Inc. (PLXP) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

PLXP · net income · updated Jun 9, 2026

Core profitability metrics

Net income was −$51.5M for FY2021 (fiscal year ending 2021-12-31), down 240.7% year-over-year. Net profit margin was -627.0%. Based on available data, PLx Pharma Inc. has been profitable since at least 2018.

FY2021 Net Income−$51.5M▼ -240.7% YoY
Trailing 12M (TTM)trailing 4 quarters sum
Net Profit Margin-627.0%−$51.5M ÷ $8.2M
YoY Change-240.7%
5-Year CAGRN/AN/A — contains loss years
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2018

▸ FMP /income-statement · Annual · PLXP net income history · PLXP profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2021Loss−$51.5M▼ 240.7%-627.0%
FY2020Loss−$15.1M▲ +29.2%-49631.9%
FY2019Loss−$21.3M▼ 2480.3%-3773.7%
FY2018★ First Profit$896,480▲ +105.8%119.0%
FY2017Loss−$15.3M▲ +28.0%-1970.9%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%
#2
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%
#3
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

PLx Pharma Inc. (PLXP) reported net income of −$51.5M for FY2021 (fiscal year ending 2021-12-31), down 240.7% year-over-year. The net profit margin was -627.0% — meaning the company kept $-6.27 of every dollar of revenue as profit.

Based on available data, PLx Pharma Inc. has been profitable since at least 2018. Net income reached a peak of $896,480 in FY2018. Data available for 10 fiscal years.

PLx Pharma Inc.'s net profit margin was -627.0% for FY2021, based on the latest annual results.

Investors sometimes search for "PLx Pharma Inc. net worth" — the company's market capitalization is a separate figure from PLXP net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

PLXP net income · 4 questions

PLx Pharma Inc. is not currently profitable on an annual basis. The company reported a net loss of $51.5M for FY2021.

is PLXP profitabledoes PLXP make a profitPLXP profitabilityPLXP profitable company

Source: FMP /income-statement · GAAP · PLx Pharma Inc. · PLx Pharma Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026